Physician profile
Brian T Dix
NPI 1679860548
$47,714.12
in general payments reported to CMS, 2019-2025
19 companies · $5,068 in 2025
The $5,068 reported for 2025 was more than what 96% of Podiatrist providers received nationally (typical 2025 total: $260).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $172 · 2020: $1,574 · 2021: $2,003 · 2022: $23K · 2023: $12K · 2024: $3,993 · 2025: $5,068.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $16K · Royalty Or License: $3,191 · Food and Beverage: $1,089 · Travel and Lodging: $708.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $16,325.00 |
| Royalty Or License | $3,190.96 |
| Food and Beverage | $1,089.40 |
| Travel and Lodging | $708.36 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Nvision Biomedical Technologies, INC. | $26,308.36 | 2021-2024 | Trigon |
| Ossio INC | $10,108.04 | 2021-2023 | |
| Treace Medical Concepts, INC. | $6,430.45 | 2020-2025 | |
| Medartis INC. | $2,125.00 | 2023 | Aptus |
| Conetic Solutions, INC. | $1,200.00 | 2021 | |
| Stryker Corporation | $255.02 | 2019-2025 | Axs Infinity Ls, Augment Injectable, 7 X 23mm Citrelock Implant |
| Flower Orthopedics Coporation | $211.17 | 2024-2025 | |
| Medline Industries LP | $163.17 | 2020-2023 | |
| International Life Sciences | $140.54 | 2024 | Flexband |
| Smith+Nephew, INC. | $129.41 | 2019-2024 | Grafix Pl |
| Organogenesis INC. | $117.61 | 2022-2023 | Puraply |
| Linvatec Corporation | $97.04 | 2025 | Biobrace 23mm |
| Acera Surgical, INC. | $80.15 | 2020 | |
| Innovation Technologies INC | $77.43 | 2021 | |
| Paragon 28, INC. | $68.55 | 2019 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Access Pro Medical, LLC | $66.34 | 2025 | Matriderm |
| Davol INC. | $66.34 | 2025 | Arista |
| Arthrex, INC. | $36.42 | 2019 | |
| Medtronic, INC. | $33.08 | 2025 | Intellis Adaptivestim |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brian Dix listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.